Christopher Moxham - Net Worth and Insider Trading
Christopher Moxham Net Worth
The estimated net worth of Christopher Moxham is at least $0 dollars as of 2024-11-13. Christopher Moxham is the Chief Scientific Officer of Fulcrum Therapeutics Inc and owns about 0 shares of Fulcrum Therapeutics Inc (FULC) stock worth over $0. Details can be seen in Christopher Moxham's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher Moxham has not made any transactions after 2021-08-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Christopher Moxham
Christopher Moxham Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher Moxham owns 1 companies in total, including Fulcrum Therapeutics Inc (FULC) .
Click here to see the complete history of Christopher Moxham’s form 4 insider trades.
Insider Ownership Summary of Christopher Moxham
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FULC | Fulcrum Therapeutics Inc | 2021-08-10 | Chief Scientific Officer |
Christopher Moxham Latest Holdings Summary
Christopher Moxham currently owns a total of 1 stock. Christopher Moxham owns 0 shares of Fulcrum Therapeutics Inc (FULC) as of August 10, 2021, with a value of $0.
Latest Holdings of Christopher Moxham
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FULC | Fulcrum Therapeutics Inc | 2021-08-10 | 0 | 3.65 | 0 |
Holding Weightings of Christopher Moxham
Christopher Moxham Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher Moxham has made a total of 1 transactions in Fulcrum Therapeutics Inc (FULC) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Fulcrum Therapeutics Inc is the sale of 51,785 shares on August 10, 2021, which brought Christopher Moxham around $911,416.
Insider Trading History of Christopher Moxham
- 1
Christopher Moxham Trading Performance
Christopher Moxham Ownership Network
Ownership Network List of Christopher Moxham
Ownership Network Relation of Christopher Moxham
Christopher Moxham Owned Company Details
What does Fulcrum Therapeutics Inc do?
Who are the key executives at Fulcrum Therapeutics Inc?
Christopher Moxham is the Chief Scientific Officer of Fulcrum Therapeutics Inc. Other key executives at Fulcrum Therapeutics Inc include Controller Greg Tourangeau , director & See Remarks Alex Sapir , and Chief Financial Officer Alan A Musso .
Fulcrum Therapeutics Inc (FULC) Insider Trades Summary
Over the past 18 months, Christopher Moxham made no insider transaction in Fulcrum Therapeutics Inc (FULC). Other recent insider transactions involving Fulcrum Therapeutics Inc (FULC) include a net sale of 5,120 shares made by Greg Tourangeau , and a net purchase of 43,360 shares made by Alex Sapir .
In summary, during the past 3 months, insiders sold 0 shares of Fulcrum Therapeutics Inc (FULC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 5,120 shares of Fulcrum Therapeutics Inc (FULC) were sold and 43,360 shares were bought by its insiders, resulting in a net purchase of 38,240 shares.
Fulcrum Therapeutics Inc (FULC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Fulcrum Therapeutics Inc Insider Transactions
Christopher Moxham Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher Moxham. You might contact Christopher Moxham via mailing address: 26 Landsdowne Street, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
